Tunahan Sarı
Tunahan Sarı has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Cüneyt Arkan
Department of Cardiovascular Surgery, Koşuyolu High Training and Research Hospital, İstanbul, Türkiye
2 shared publications - Mehmet Erdem Toker
Department of Cardiovascular Surgery, Kartal Kosuyolu High Specialization Training and Research Hospital University of Health Sciences, 34846 Istanbul, Türkiye
2 shared publications - Ömer Faruk Akardere
Department of Cardiovascular Surgery, Kartal Kosuyolu Heart Research and Training Hospital, Istanbul, Türkiye
2 shared publications - Ahmet Erdal Tasci
Department of Thoracic Surgery, Kartal Kosuyolu High Specialization Education & Research Hospital, Istanbul, Turkey
1 shared publication - Erdal Polat
University of Health Sciences, Türkiye
1 shared publication - Fatih Yiğit
Department of Cardiovascular Surgery, University of Health Sciences, Koşuyolu High Specialization Education and Research Hospital, Istanbul, Türkiye
1 shared publication
Latest Publications
- Open Access
- 1 December 2025
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 28 (3) , 107-112
Off-pump or On-pump? Single-vessel Coronary Artery Bypass Grafting Surgery
Objectives: Off-pump coronary artery bypass grafting (OPCAB) was introduced to avoid the adverse effects of cardiopulmonary bypass used in on-pump coronary artery bypass grafting (ONCAB). While OPCAB is performed on a beating heart, often in a more challenging surgical field, ONCAB provides a stable, bloodless environment with the heart arrested. Despite extensive research comparing the two techniques, consensus on the optimal approach, particularly for single-vessel disease, remains unclear. Single-vessel disease accounts for approximately 3% of coronary bypass cases, with surgical intervention often preferred for proximal left anterior descending artery (LAD) lesions. Methods: A total of 336 patients aged 20–80 who underwent elective or emergency LAD bypass between 2015 and 2021 were included in the study. Patients were divided into OPCAB (n=125) and ONCAB (n=211) groups. Exclusion criteria included concomitant surgeries, prior cardiac surgery, endarterectomy, non-LAD single-vessel bypass, redo surgeries, hemodynamic instability, and severe arrhythmias. Pre-operative (age, gender, ejection fraction [EF], diabetes, chronic kidney disease), intraoperative (use of left internal mammary artery), and post-operative outcomes (drainage, transfusions, complications, intensive care unit (ICU)/hospital stay, 30- day mortality) were analyzed. Emergency cases included unstable angina or myocardial infarction, while elective cases involved stable coronary disease. Results: Results indicated that the OPCAB group had older patients with lower EFs. There were no significant differences in post-operative complications or mortality rates between the two groups, although OPCAB patients experienced shorter ICU and hospital stays. Importantly, OPCAB demonstrated comparable effectiveness to ONCAB, particularly in older patients and those with lower EFs. Factors influencing mortality included new-onset cerebrovascular accidents and acute renal failure. Conclusion: This study contributes to the limited literature on single-vessel disease and suggests that OPCAB should be considered the first choice in suitable patients due to its reliability and potential benefits. Further research is encouraged to explore these findings in a broader context.
- 1 December 2025
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 28 (3) , 107-112
Open AccessOff-pump or On-pump? Single-vessel Coronary Artery Bypass Grafting Surgery
Objectives: Off-pump coronary artery bypass grafting (OPCAB) was introduced to avoid the adverse effects of cardiopulmonary bypass used in on-pump coronary artery bypass grafting (ONCAB). While OPCAB is performed on a beating heart, often in a more challenging surgical field, ONCAB provides a stable, bloodless environment with the heart arrested. Despite extensive research comparing the two techniques, consensus on the optimal approach, particularly for single-vessel disease, remains unclear. Single-vessel disease accounts for approximately 3% of coronary bypass cases, with surgical intervention often preferred for proximal left anterior descending artery (LAD) lesions. Methods: A total of 336 patients aged 20–80 who underwent elective or emergency LAD bypass between 2015 and 2021 were included in the study. Patients were divided into OPCAB (n=125) and ONCAB (n=211) groups. Exclusion criteria included concomitant surgeries, prior cardiac surgery, endarterectomy, non-LAD single-vessel bypass, redo surgeries, hemodynamic instability, and severe arrhythmias. Pre-operative (age, gender, ejection fraction [EF], diabetes, chronic kidney disease), intraoperative (use of left internal mammary artery), and post-operative outcomes (drainage, transfusions, complications, intensive care unit (ICU)/hospital stay, 30- day mortality) were analyzed. Emergency cases included unstable angina or myocardial infarction, while elective cases involved stable coronary disease. Results: Results indicated that the OPCAB group had older patients with lower EFs. There were no significant differences in post-operative complications or mortality rates between the two groups, although OPCAB patients experienced shorter ICU and hospital stays. Importantly, OPCAB demonstrated comparable effectiveness to ONCAB, particularly in older patients and those with lower EFs. Factors influencing mortality included new-onset cerebrovascular accidents and acute renal failure. Conclusion: This study contributes to the limited literature on single-vessel disease and suggests that OPCAB should be considered the first choice in suitable patients due to its reliability and potential benefits. Further research is encouraged to explore these findings in a broader context.
- Open Access
- 1 April 2022
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 25 (1) , 1-5
Early and Long Term Results of Our Open Heart Surgical Operations in the Presence of Active Oncological Diseases
Introduction: Active cancer and heart disease, which share similar environmental and biological characteristics, can occur concomitantly. Open heart surgery may be required for these patients when indicated. This study aims to demonstrate the early and long-term results and discuss the intervention strategy in patients with different types of active malignancies, who underwent open-heart surgery. Patients and Methods: Between January 2012 and May 2020, open-heart surgery was performed on 10 patients with active malignancies. The mean age was 65.5 (52-77), and four of the patients were female. Two patients were operated on urgently due to advanced pleural effusion. AVR+CABG, CABG, CABG+left upper lobectomy, and AVR+MVR were performed in four patients with lung cancer; AVR+CABG were performed in one patient with colon cancer; CABG was performed in four patients each with one of the following conditions: lymphoma, breast cancer, essential thrombocytosis, meningioma); and mass resection operation from the left atrium and left ventricle was performed in one patient with osteosarcoma. Results: Eight patients were discharged and two patients died in the early postoperative period. Postoperative left hemiparesis developed in one patient. Six-month, one-year and five-year survival rates were 79%, 37.5% and 25%, respectively. Conclusion: Open-heart surgery can be successfully performed with acceptable mortality and morbidity rates on the high-risk patient group with active cancer.
- 1 April 2022
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 25 (1) , 1-5
Open AccessEarly and Long Term Results of Our Open Heart Surgical Operations in the Presence of Active Oncological Diseases
Introduction: Active cancer and heart disease, which share similar environmental and biological characteristics, can occur concomitantly. Open heart surgery may be required for these patients when indicated. This study aims to demonstrate the early and long-term results and discuss the intervention strategy in patients with different types of active malignancies, who underwent open-heart surgery. Patients and Methods: Between January 2012 and May 2020, open-heart surgery was performed on 10 patients with active malignancies. The mean age was 65.5 (52-77), and four of the patients were female. Two patients were operated on urgently due to advanced pleural effusion. AVR+CABG, CABG, CABG+left upper lobectomy, and AVR+MVR were performed in four patients with lung cancer; AVR+CABG were performed in one patient with colon cancer; CABG was performed in four patients each with one of the following conditions: lymphoma, breast cancer, essential thrombocytosis, meningioma); and mass resection operation from the left atrium and left ventricle was performed in one patient with osteosarcoma. Results: Eight patients were discharged and two patients died in the early postoperative period. Postoperative left hemiparesis developed in one patient. Six-month, one-year and five-year survival rates were 79%, 37.5% and 25%, respectively. Conclusion: Open-heart surgery can be successfully performed with acceptable mortality and morbidity rates on the high-risk patient group with active cancer.